Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF and Handfield-Jones SE. British Association of Dermatologists' guidelines for the management of cutaneous warts 2014.Br J Dermatol. 2014; 171(4): 696-712.
2. Rhea WG jr, Bourgeois BM and Sewell DR. Condyloma acuminata: a fatal disease? Am Surg. 1998. 64(11):1082-7.
3. Scott M, Nakagawa M and Moscicki AB. Cell-Mediated Immune Response to Human Papillomavirus Infection. Clin Diagn Lab Immunol. 2001; 8(2): 209–220.
4. Onishi RM and Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease, Immunology. 2010; 129(3): 311–321.
5. Fischer SM, Boehner A, Eyerich S, Carbone T, Traidl-Hoffmann C, Schmidt-Weber CB, Cavani A, Ring J, Hein R and Eyerich K. Differential in situ expression of IL-17 in skin diseases. Eur J Dermatol. 2012; 22(6):781-4.
6. Bruggink SC, Eekhof JA, Egberts PF, van Blijswijk SC, Assendelft WJ, Gussekloo J. Natural course of cutaneous warts amongprimary schoolchildren: A Prospective Cohort Study, Journal List Ann Fam, 2013; 11(5):437-41.
7. Piaserico S, Sandini E, Peserico A and Alaibac M. Cutaneous viral infections in organ transplant patients. Giornale italiano Dermatol Venereol. 2014; 149(4):409-15.
8. Scott M, Nakagawa M and Moscicki AB. Cell-Mediated Immune Response to Human Papillomavirus Infection. Clin Diagn Lab Immunol. 2001; 8(2): 209–220.
9. Horn TD, Johnson SM, Helm RM and Roberson PK. Intralesional Immunotherapy of Warts with Mumps, Candida, and Trichophyton Skin Test Antigens. Arch Dermatol. 2005; 141(5):589-5.